Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Vioguard Ultraviolet Keyboard Proven to Eradicate Ebola, Flu and C. Diff
  • USA - English


News provided by

Vioguard

Apr 25, 2018, 07:00 ET

Share this article

Share toX

Share this article

Share toX

The Vioguard Defender is a self-sanitizing ultraviolet keyboard.
The Vioguard Defender is a self-sanitizing ultraviolet keyboard.

PORTLAND, Ore. (PRWEB) April 25, 2018 -- Last week, researchers from Case Western Reserve University and Louis Stokes Cleveland VA Medical Center presented a poster that examined the efficacy of the FDA-cleared Vioguard Defender, a self-sanitizing ultraviolet (UV-C) keyboard at The Society for Healthcare Epidemiology of America (SHEA) conference.

The device is automatic and addresses a commonly forgotten source of disease transfer—the keyboard. The UV-C device provides automatic denomination of shared keyboards. After each use, the keyboard automatically retreats into a fully-enclosed console.

Vioguard significantly reduced the transmission to subsequently touched items. The Defender proved effective against all three viruses.

Post this

During the poster presentation at SHEA, one EPI doctor commented “I cannot recommend any UV-C devices with the exception of the Vioguard Defender.”

Other onlookers agreed the device should be used in every workstation on wheels all shared workstations in hospitals.

The evaluation also concluded that the “automated decontamination of keyboards could reduce dissemination of viruses and bacteria in healthcare settings.”

The study tested the efficacy of the Defender and resulting reduction in pathogens transferred to other objects, resulting in a zero-transfer risk. The objects used included a stapler, a telephone and a patient chart.

The device was tested against the Ebola, flu strains and C. diff. The first step in the testing process was contaminating the keyboards with the pathogens. Test subjects touched either the control or the UV-treated keyboards and then touched the three objects listed above. The keyboard and the items were then sampled for the pathogens.

The result was that “Vioguard significantly reduced the transmission to subsequently touched items,” according to the poster. The Defender proved effective against all three pathogens.

The study and poster were completed independently from Vioguard, with Vioguard maintaining no role in the study design or interpretation of the results.

Many nurses who listened to the poster presentation admitted they had no idea when the last time the keyboards in their hospitals were cleaned. One NICU/IP nurse said “The automatic sanitizing feature ensures zero transfer without impacting workflow.”

Numerous studies document pathogen transfer from keyboards to clinicians and surfaces within hospitals. Correct PPE protocol, hand hygiene and regular cleaning of keyboards does help reduce disease transfer onto the surface of the keyboards, but they do not eliminate those risks.

During the study, researchers concluded an enclosed UV-C device (Vioguard Defender) provided effective, automated and safe decontamination of keyboards and achieves a zero-transfer risk.

Vioguard offers multiple, intuitive solutions that are affordable, innovative and automatic, by eliminating common sources of cross-contamination in healthcare environments.

For more information about joining the fight against pathogens, please visit the Vioguard website at http://www.vioguard.com.

Researchers:
Heba Alhmidi, MD (Research Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio); Aaron A. Shaikh, MSW (Geriatric Research, Education and Clinical Center, Cleveland VA Medical Center, Cleveland, Ohio); Jennifer L. Cadnum, BS (Department of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, Ohio); Curtis J. Donskey, MD (Geriatric Research, Education and Clinical Center, Cleveland VA Medical Center, Cleveland, Ohio & Department of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, Ohio).

Casey Archibald, Vioguard, http://www.vioguard.com, +1 (425) 318-7900, [email protected]

Modal title

Fig. 1 Simulation setup for virus transfer from keyboards to fingerpads and three subsequent items.
Fig. 1 Simulation setup for virus transfer from keyboards to fingerpads and three subsequent items.
Fig. 2 Transmission of PHI X147
Fig. 2 Transmission of PHI X147
Fig. 3 Reduction of Organisms Exposed to Vioguard
Fig. 3 Reduction of Organisms Exposed to Vioguard
Fig. 1 Simulation setup for virus transfer from keyboards to fingerpads and three subsequent items. Fig. 2 Transmission of PHI X147 Fig. 3 Reduction of Organisms Exposed to Vioguard

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.